Voloridge Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.2M Buy
1,474,155
+1,016,827
+222% +$17.4M 0.09% 274
2025
Q1
$29.2M Buy
+457,328
New +$29.2M 0.11% 258
2024
Q4
Sell
-38,973
Closed -$4.87M 1368
2024
Q3
$4.87M Sell
38,973
-249,644
-86% -$31.2M 0.02% 783
2024
Q2
$45.6M Sell
288,617
-141,852
-33% -$22.4M 0.17% 182
2024
Q1
$55.7M Buy
430,469
+71,921
+20% +$9.31M 0.2% 136
2023
Q4
$34.6M Buy
358,548
+260,569
+266% +$25.1M 0.14% 196
2023
Q3
$11.9M Buy
97,979
+2
+0% +$242 0.06% 415
2023
Q2
$11.2M Sell
97,977
-196,233
-67% -$22.5M 0.05% 433
2023
Q1
$40.6M Buy
294,210
+133,341
+83% +$18.4M 0.2% 148
2022
Q4
$20.8M Buy
160,869
+95,066
+144% +$12.3M 0.12% 253
2022
Q3
$7.27M Buy
65,803
+46,813
+247% +$5.17M 0.04% 536
2022
Q2
$1.42M Sell
18,990
-116,161
-86% -$8.7M 0.01% 1106
2022
Q1
$10.6M Sell
135,151
-10,171
-7% -$795K 0.06% 396
2021
Q4
$13.1M Sell
145,322
-35,745
-20% -$3.22M 0.07% 391
2021
Q3
$16.7M Sell
181,067
-153,404
-46% -$14.2M 0.11% 257
2021
Q2
$26M Sell
334,471
-197,484
-37% -$15.4M 0.18% 135
2021
Q1
$39.6M Buy
+531,955
New +$39.6M 0.29% 74
2020
Q3
Sell
-29,240
Closed -$4.69M 1489
2020
Q2
$4.69M Buy
+29,240
New +$4.69M 0.05% 369
2019
Q4
Sell
-115,270
Closed -$8.68M 1339
2019
Q3
$8.68M Buy
+115,270
New +$8.68M 0.15% 154
2019
Q1
Sell
-40,684
Closed -$4.44M 1052
2018
Q4
$4.44M Buy
+40,684
New +$4.44M 0.2% 121
2018
Q3
Sell
-137,118
Closed -$18.1M 451
2018
Q2
$18.1M Sell
137,118
-28,848
-17% -$3.81M 0.49% 48
2018
Q1
$12.3M Buy
165,966
+10,562
+7% +$783K 0.29% 56
2017
Q4
$8.65M Buy
+155,404
New +$8.65M 0.19% 132
2017
Q1
Sell
-159,580
Closed -$4.38M 675
2016
Q4
$4.38M Buy
159,580
+155,880
+4,213% +$4.28M 0.09% 276
2016
Q3
$227K Buy
+3,700
New +$227K ﹤0.01% 209
2015
Q4
Sell
-37,997
Closed -$1.22M 295
2015
Q3
$1.22M Buy
+37,997
New +$1.22M 0.06% 210